Michael R. Slater

Geen lopende functies

77 jaar

Health Technology

Consumer Services

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Michael Heffernan	M	59	SYNLOGIC, INC.	4 jaar

Meer zien

Relatiegrafiek

Connectie in verschillende bedrijven

Oude connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Richard Peters	M	61	MERRIMACK PHARMACEUTICALS, INC.	2 jaar
Charles Sherwood	M	76	ANIKA THERAPEUTICS, INC.	20 jaar
Jean Franchi	F	57	MERRIMACK PHARMACEUTICALS, INC.	2 jaar
Todd Shegog	M	59	SYNLOGIC, INC.	3 jaar
Yasir Al-Wakeel	M	42	MERRIMACK PHARMACEUTICALS, INC.	2 jaar
J. Engle	M	74	ANIKA THERAPEUTICS, INC.	5 jaar
Walter A. Gilbert	M	92	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	7 jaar
Anthony Sinskey	M	83	MERRIMACK PHARMACEUTICALS, INC.	22 jaar
William A. Sullivan	M	52	MERRIMACK PHARMACEUTICALS, INC.	10 jaar
Mark B. Skaletsky	M	75	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	7 jaar
Robert J. Mulroy	M	59	MERRIMACK PHARMACEUTICALS, INC.	17 jaar
Sarah Nash	F	70	MERRIMACK PHARMACEUTICALS, INC.	8 jaar
Vivian Lee	M	57	MERRIMACK PHARMACEUTICALS, INC.	4 jaar
Jeffrey A. Munsie	M	47	MERRIMACK PHARMACEUTICALS, INC.	8 jaar
Ken Bate	M	73	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	6 jaar
James van B. Dresser	M	82	MERRIMACK PHARMACEUTICALS, INC.	15 jaar
George Demetri	M	67	MERRIMACK PHARMACEUTICALS, INC.	2 jaar
John Dineen	M	61	MERRIMACK PHARMACEUTICALS, INC.	4 jaar
Jonathan Rothbard	M	72	ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN.	6 jaar
James Quigley	M	71	MERRIMACK PHARMACEUTICALS, INC.	7 jaar
Gavin MacBeath	M	54	MERRIMACK PHARMACEUTICALS, INC.	24 jaar
William McClements	M	60	MERRIMACK PHARMACEUTICALS, INC.	6 jaar
Daryl C. Drummond	M	-	MERRIMACK PHARMACEUTICALS, INC.	-
Michael Porter	M	76	MERRIMACK PHARMACEUTICALS, INC.	8 jaar
Michael Burgess	M	61	SYNLOGIC, INC.	4 jaar
Michael Powell	M	69	SYNLOGIC, INC.	3 jaar
Walter M. Lovenberg	M	89	MERRIMACK PHARMACEUTICALS, INC.	12 jaar
Lisa Kelly-Croswell	F	57	SYNLOGIC, INC.	3 jaar
John Mendelsohn	M	87	MERRIMACK PHARMACEUTICALS, INC.	5 jaar
Russ Ray	M	77	MERRIMACK PHARMACEUTICALS, INC.	7 jaar
Michael Astrue	M	67	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	6 jaar
Gordon J. Fehr	M	90	MERRIMACK PHARMACEUTICALS, INC.	16 jaar
Samuel Agresta	M	51	MERRIMACK PHARMACEUTICALS, INC.	1 jaar
Ellen K. Forest	F	60	MERRIMACK PHARMACEUTICALS, INC.	-
Kathleen Gallagher	F	-	MERRIMACK PHARMACEUTICALS, INC.	13 jaar
Jamie Austin	M	-	SYNLOGIC, INC.	-
Michael Alfieri	M	59	MERRIMACK PHARMACEUTICALS, INC.	3 jaar
Daniel Rosan	M	-	SYNLOGIC, INC.	1 jaar
Scott Lauder	M	-	MERRIMACK PHARMACEUTICALS, INC.	3 jaar
Birgit M. Schoeberl	M	-	MERRIMACK PHARMACEUTICALS, INC.	2 jaar
Andrew Marsh	M	-	SYNLOGIC, INC.	1 jaar
Dana Robie	F	-	MERRIMACK PHARMACEUTICALS, INC.	4 jaar
Richard Riese	M	61	SYNLOGIC, INC.	2 jaar
Hewmun Lau	F	-	MERRIMACK PHARMACEUTICALS, INC.	2 jaar
Alexey A. Lugovskoy	M	51	MERRIMACK PHARMACEUTICALS, INC.	6 jaar
John L. Green	M	44	MERRIMACK PHARMACEUTICALS, INC.	-
Thomas Wickham	M	-	MERRIMACK PHARMACEUTICALS, INC.	7 jaar
David L. Hava	M	49	SYNLOGIC, INC.	3 jaar
Sergio Santillana	M	61	MERRIMACK PHARMACEUTICALS, INC.	2 jaar
Patricia A. Murphy	F	65	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	3 jaar
Roy R. Lobb	M	-	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	-
John Green	M	43	MERRIMACK PHARMACEUTICALS, INC.	1 jaar
Francesco J. Luppino	M	55	ANIKA THERAPEUTICS, INC.	8 jaar
Sarah P. Cecil	F	72	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	6 jaar
William J. Mrachek	M	80	ANIKA THERAPEUTICS, INC.	-
Burt Adelman	M	71	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	-
Timothy M. Kish	M	72	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	7 jaar
Frederick B. Oleson	M	-	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	5 jaar
John Alam	M	62	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	6 jaar
Sean Moran	M	66	ANIKA THERAPEUTICS, INC.	7 jaar
Joseph M. Davie	M	84	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	7 jaar
Gregg Beloff	M	56	SYNLOGIC, INC.	3 jaar
Morris Z. Rosenberg	M	64	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	8 jaar
Harry M. Meade	M	77	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	9 jaar
Mark Stejbach	M	61	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	3 jaar
Thomas E. Needham	M	60	MERRIMACK PHARMACEUTICALS, INC.	1 jaar
Dominique Sémon	M	-	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	4 jaar
James G. Barsoum	M	67	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	16 jaar
Elan Ezickson	M	60	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	2 jaar
Edward Gaj	M	67	ANIKA THERAPEUTICS, INC.	9 jaar
Victor E. Kotelianski	M	-	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	-
Robert A. Hamm	M	72	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	9 jaar
Edward J. Stewart	M	53	MERRIMACK PHARMACEUTICALS, INC.	16 jaar
Lisa A. Evrén	F	-	MERRIMACK PHARMACEUTICALS, INC.	3 jaar
Cary Pfeffer	M	61	Biogen MA, Inc. Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.	10 jaar
Peter N. Laivins	M	66	MERRIMACK PHARMACEUTICALS, INC.	6 jaar
Jim Murray	M	-	MERRIMACK PHARMACEUTICALS, INC.	14 jaar

Statistieken

Land	Connecties	% van het totaal
Verenigde Staten	78	100.00%

Ouderdom van de connecties

Actief

Verleden

Man

Vrouw

Besturend

Uitvoerend

Oorsprong van de connecties

Beurs
Insiders
Michael R. Slater
Persoonlijk netwerk